Clinical Trial Update: Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing fast-acting insulin aspart to NovoRapid/NovoLog in people with type 2 diabetes has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Fast-acting Insulin Aspart (insulin aspart)
• NovoRapid (insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2020-03-12